MDAI READ THE FULL DYAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ: MDAI) reported 2025 results on March 24 th after the ...

Spectral AI, Inc. (NASDAQ:MDAI) Q4 2025 Earnings Call Transcript March 24, 2026 Spectral AI, Inc. beats earnings expectations ...

The de novo application for DeepView was submitted in June 2025, followed by a timely response to the FDA's additional ...

Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral ...

Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, ...

Spectral AI, a leading developer of innovative diagnostic tools, has released its 2025 fourth quarter and full year financial ...

Spectral AI (NASDAQ:MDAI) executives said fiscal 2025 marked a “pivotal year” as the company advanced its DeepView burn ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

Spectral AI Inc MDAI stock is trading higher Thursday morning after the medical diagnostics company said it received $31.7 ...

Spectral AI received $31.7 million of funding from the Biomedical Advanced Research and Development Authority to speed the development of its DeepView System, an artificial-intelligence tool for burn ...

This immediate, non-dilutive funding is being advanced in addition to the $54.9 million of funding committed to date as part of the Company’s current contract with BARDA (the “BARDA Contract”) valued ...

DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...